Revolution Medicines says its potential breakthrough pancreatic cancer drug succeeds in
Revolution Medicines’ drug for pancreatic cancer succeeded in a highly anticipated Phase 3 trial, almost doubling the typical length of
Read MoreRevolution Medicines’ drug for pancreatic cancer succeeded in a highly anticipated Phase 3 trial, almost doubling the typical length of
Read MoreEli Lilly Biotechnology Center is shown in San Diego, California, March 1, 2023. Mike Blake | Reuters Eli Lilly on
Read MoreCongressman Gerry Connolly (D-VA) questions witnesses during a House Committee on Oversight and Government Reform hearing titled “A Hearing with
Read MoreModerna and Merck released more positive three-year data Monday on their experimental vaccine, given to patients with the most deadly
Read MoreSubscribe to our mailing list and get interesting stuff and updates to your email inbox.
Thank you for subscribing.
Something went wrong.